Published in Drug Metab Dispos on November 01, 2000
Genome-wide association studies in pharmacogenomics. Nat Rev Genet (2010) 2.14
Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy. Clin Pharmacokinet (2016) 0.99
Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon. Br J Clin Pharmacol (2014) 0.97
Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements. Eur J Clin Pharmacol (2009) 0.91
Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction. Eur J Clin Pharmacol (2007) 0.87
Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro. Eur J Clin Pharmacol (2004) 0.86
Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice. Eur J Clin Pharmacol (2008) 0.82
Exploration of the binding of proton pump inhibitors to human P450 2C9 based on docking and molecular dynamics simulation. J Mol Model (2010) 0.78
A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population. PLoS One (2016) 0.75
Pharmacokinetic drug-drug interaction of the novel anticancer agent E7070 and acenocoumarol. Invest New Drugs (2004) 0.75
Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital. Eur J Clin Pharmacol (2012) 0.75
Rofecoxib interaction with oral anticoagulant acenocoumarol. Eur J Clin Pharmacol (2003) 0.75
Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets. J Comput Aided Mol Des (2007) 0.75
Therapeutic efficacy of acenocoumarol in a warfarin-resistant patient with deep venous thrombosis: a case report. Eur J Clin Pharmacol (2009) 0.75
Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem (1986) 2.31
Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A (1986) 1.45
Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther (1990) 1.38
Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol (1991) 1.37
Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology (1994) 1.28
Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death. Am J Transplant (2008) 1.26
Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochem Pharmacol (1992) 1.12
Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol (1992) 1.09
Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. J Clin Invest (1990) 1.04
Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide. Biochem Pharmacol (1994) 1.00
Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. Mol Pharmacol (1991) 0.97
Polymorphism of human cytochrome P-450. Xenobiotica (1987) 0.97
Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Res (1992) 0.96
Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes. Chem Res Toxicol (2001) 0.95
Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica (1992) 0.95
Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem (1989) 0.94
Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes. Drug Metab Dispos (1991) 0.93
Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth (1998) 0.92
In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes. J Pharmacol Exp Ther (1999) 0.91
Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes. Drug Metab Dispos (1986) 0.91
Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples. Carcinogenesis (1991) 0.89
Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes. Catalysis by a cytochrome P450 IIC different from that responsible for mephenytoin hydroxylation. Biochem Pharmacol (1991) 0.88
Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology (1991) 0.88
Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake. Eur J Clin Invest (1989) 0.87
Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9. Mol Pharmacol (1996) 0.86
The use of human in vitro metabolic parameters to explore the risk assessment of hazardous compounds: the case of ethylene dibromide. Toxicol Appl Pharmacol (1997) 0.85
Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies. Mol Pharmacol (1994) 0.83
Is diclofenac a valuable CYP2C9 probe in humans? Eur J Clin Pharmacol (2001) 0.83
Purification of a new cytochrome P-450 from human liver microsomes. Biochim Biophys Acta (1985) 0.83
Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. Chem Res Toxicol (1994) 0.83
Cytochrome P-450 enzymes involved in genetic polymorphism of drug oxidation in humans. Biochem Soc Trans (1987) 0.82
Partial purification of human liver cytochrome P 450. Biochem Biophys Res Commun (1979) 0.82
Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line. Mol Pharmacol (1995) 0.82
Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10. Eur J Biochem (1993) 0.82
Effect of microsomal preparations and induction on cytochrome P-450-dependent monooxygenases in fetal and neonatal rat liver. Biochem Pharmacol (1979) 0.82
Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma. Carcinogenesis (1993) 0.81
Drug-induced immunotoxicity. Eur J Drug Metab Pharmacokinet (1999) 0.81
Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium. Hepatology (1999) 0.80
The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways. J Pharmacol Exp Ther (1996) 0.80
Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis. Pharmacogenetics (1997) 0.79
Immunochemical characterization of some monooxygenase activities in liver microsomes from untreated and phenobarbital-treated rats. Biochem Biophys Res Commun (1981) 0.79
Presence of proteins recognized by mammalian cytochrome P-450 antibodies in Euglena gracilis. Biochim Biophys Acta (1993) 0.79
Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug. Mol Pharmacol (1992) 0.78
Cytochrome P450 induction and mutagenicity of 2-aminoanthracene (2AA) in rat liver and gut. Mutat Res (1992) 0.78
Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies. Toxicology (1996) 0.78
Drug-metabolizing enzymes in human foetal liver: partial resolution of multiple cytochromes P 450. Pediatr Pharmacol (New York) (1982) 0.78
Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5. J Pharm Pharmacol (1999) 0.78
[Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors]. Bull Cancer (1993) 0.78
Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur J Biochem (1990) 0.78
Hepatic cytochrome P450 and UDP-glucuronosyl transferase are affected by five sources of dietary fiber in germ-free rats. J Nutr (1996) 0.78
Hydrophobic chromatography: a one-step method for the purification of human liver microsomal epoxide hydrolase. J Chromatogr (1988) 0.77
Effects of various inducers on the expression of cytochromes P-450 IIC8, 9, 10 and IIIA in cultured adult human hepatocytes. Toxicol In Vitro (1990) 0.77
Expression of cytochrome P450 in rat pleural mesothelial cells in secondary cultures. J Cell Physiol (1994) 0.77
Effects of the bacterial status of rats on the changes in some liver cytochrome P450 (EC 1.14.14.1) apoproteins consequent to a glucosinolate-rich diet. Br J Nutr (1998) 0.76
Effects of ethanol and clofibrate on expression of cytochrome P-450 enzymes and epoxide hydrolase in cultures and cocultures of rat hepatocytes. Eur J Biochem (1991) 0.75
CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines. Environ Toxicol Pharmacol (1996) 0.75
Inter-individual variability in the oxidation of 1,2-dibromoethane: use of heterologously expressed human cytochrome P450 and human liver microsomes. Chem Biol Interact (1996) 0.75
Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450. Br J Clin Pharmacol (1983) 0.75
Metabolism rate of oxodipine in rats and humans: comparison of in vivo and in vitro data. J Pharmacol Exp Ther (1992) 0.75
Pregnenolone-7beta-hydroxylating activity of human cytochrome P450-1A1. J Steroid Biochem Mol Biol (1997) 0.75
High yield purification and characterization of engineered human P450 1A2 and generation of immuno-inhibitor antibodies. Pharmacogenetics (1999) 0.75
Enzymatic and immunological evidences that phenobarbital induces cytochrome P 450 in fetal and neonatal rat liver. Biochem Biophys Res Commun (1982) 0.75
Autoantibodies against a kidney--liver protein associated with quinolone-induced acute interstitial nephritis or hepatitis. Nephrol Dial Transplant (1997) 0.75
Induction of cytochrome P-450 in rat liver by the antibiotic troleandomycin: partial purificaton and properties of cytochrome P-450-troleandomycin metabolite complexes. Biochem Biophys Res Commun (1981) 0.75
Effects of ethanol, dexamethasone and RU 486 on expression of cytochromes P450 2B, 2E, 3A and glutathione transferase pi in a rat hepatoma cell line (Fao). Pharmacogenetics (1992) 0.75
Influence of ethanol and benzene on cytochrome P-450 fractions in rat liver microsomes. Drug Metab Dispos (1983) 0.75
Identification of the highly polymorphic S-mephenytoin hydroxylase in humans. Arch Toxicol Suppl (1996) 0.75
Use of heterologous expression systems to study autoimmune drug-induced hepatitis. Methods Enzymol (1996) 0.75